RECALL Contour PLUS Blood Glucose Test Strips

SOL #: 36C25726F0091JustificationSole Source

Overview

Buyer

Veterans Affairs
Veterans Affairs, Department Of
257-NETWORK CONTRACT OFFICE 17 (36C257)
San Antonio, TX, 78240, United States

Place of Performance

Dallas, TX

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413)

PSC

In Vitro Diagnostic Substances, Reagents, Test Kits And Sets (6550)

Set Aside

No set aside specified

Timeline

1
Posted
Jun 5, 2026

Qualification Details

Fit reasons
  • NAICS alignment with historical contract wins in similar service areas.
  • Scope strongly matches core technical capabilities and delivery model.
Risks
  • Past performance thresholds may require one additional teaming partner.
  • Potential clarification needed on staffing minimums before bid/no-bid.
Next steps

Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.

Quick Summary

The Department of Veterans Affairs (VA), specifically VISN 17, North Texas Veterans Health Care System in Dallas, TX, has issued a Justification for Other Than Full and Open Competition for the urgent procurement of CONTOUR PLUS Blood Glucose Test Strips and associated replacement system kits. This action is critical to address an FDA-classified Class I Recall affecting current glucose monitoring supplies, ensuring continuity of safe diabetic care for veterans.

Scope of Work

This procurement covers:

  • CONTOUR PLUS Blood Glucose Test Strips, 50-count (Item #00193)
  • CONTOUR PLUS System Kits, including meters and necessary accessories for full recall replacement
  • Direct shipment of these items to affected veterans

Contract & Timeline

  • Type: Firm-Fixed Price
  • Period of Performance: June 3, 2026, through July 29, 2027
  • Set-Aside: None (Sole Source Justification)
  • Published: June 5, 2026
  • Estimated Value: Not specified (redacted in justification document)

Evaluation

This is a sole-source award justified to Ascensia Diabetes Care US Inc. under the authority of "Unusual and Compelling Urgency" (41 USC §3304(a)(2)). Market research confirmed Ascensia as the Original Equipment Manufacturer (OEM) and the only source capable of supplying the required FDA-cleared replacement materials within the necessary timeframe. No alternative or equivalent products were found to meet the technical requirements.

Additional Notes

  • The items will be acquired through the mandatory NAC Contract 36F79724D0097.
  • Market research supporting this justification was conducted on May 28, 2026.
  • The VA will continue to monitor future requirements for potential competitive opportunities.

People

Points of Contact

Ivan T. TorresPRIMARY

Files

Files

Download

Versions

Version 1Viewing
Justification
Posted: Jun 5, 2026
RECALL Contour PLUS Blood Glucose Test Strips | GovScope